Update: 50 percent of patients in new brain cancer study alive after five years
Sunday, November 24, 2013 - 11:00
in Health & Medicine
Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors – glioblastoma multiforme – survived longer than five years after diagnosis, according to new research.